T1	Action 19 22	use
T2	Concept 36 47	information
T3	Concept 26 35	available
R1	has-property Arg1:T2 Arg2:T3	
T4	Concept 68 76	epitopes
T5	Concept 59 67	SARS-CoV
R2	has-property Arg1:T4 Arg2:T5	
T6	Concept 110 121	predictions
T7	Concept 97 109	bionformatic
R3	target Arg1:T1 Arg2:T2	
R4	has-property Arg1:T2 Arg2:T5	
R5	has-property Arg1:T6 Arg2:T7	
T8	Action 122 128	points
T9	Concept 141 148	regions
T10	Concept 132 140	specific
R6	has-property Arg1:T9 Arg2:T10	
T11	Concept 152 161	2019-nCoV
R7	has-part Arg1:T11 Arg2:T9	
R8	subject Arg1:T8 Arg2:T7	
R9	subject Arg1:T8 Arg2:T1	
R10	target Arg1:T8 Arg2:T9	
T13	Action 200 210	recognized
T14	Concept 214 236	human immune responses
R11	target Arg1:T13 Arg2:T14	
R12	subject Arg1:T13 Arg2:T11	
T12	Concept 241 246	virus
T15	Concept 275 282	similar
T16	Concept 263 274	genetically
R13	has-property Arg1:T15 Arg2:T16	
T17	Concept 306 311	virus
T18	Concept 295 305	SARS-CoV-1
R14	is-a Arg1:T17 Arg2:T18	
T19	Concept 290 294	2003
R15	in-time Arg1:T18 Arg2:T19	
R16	has-property Arg1:T12 Arg2:T15	
R17	in-context Arg1:T15 Arg2:T17	
T20	Concept 349 356	aspects
T21	Concept 360 372	epidemiology
T22	Concept 379 386	similar
R18	has-part Arg1:T21 Arg2:T20	
R19	has-property Arg1:T20 Arg2:T22	
T23	Concept 410 415	views
T24	Action 428 434	emerge
T25	Concept 423 427	data
T26	Concept 419 422	new
T27	Action 397 403	update
T28	Action 337 343	expect
T29	Concept 323 333	reasonable
R20	has-property Arg1:T28 Arg2:T29	
R21	causes Arg1:T15 Arg2:T28	
R22	subject Arg1:T28 Arg2:T20	
R23	target Arg1:T27 Arg2:T23	
R24	target Arg1:T24 Arg2:T25	
R25	has-property Arg1:T25 Arg2:T26	
T30	Concept 491 498	PWK/PhJ
T31	Concept 483 490	founder
R26	has-property Arg1:T30 Arg2:T31	
T32	Action 512 518	driver
T33	Concept 526 534	SARS-CoV
T34	Concept 535 540	titer
R27	has-property Arg1:T34 Arg2:T33	
A1	Diminished T34
R28	subject Arg1:T32 Arg2:T30	
R29	target Arg1:T32 Arg2:T34	
T35	Concept 548 552	lung
R30	in-place Arg1:T34 Arg2:T35	
T36	Concept 435 443	Analysis
T37	Concept 457 464	effects
T38	Concept 454 456	60
R31	has-property Arg1:T37 Arg2:T38	
T39	Action 465 473	revealed
R32	subject Arg1:T39 Arg2:T36	
R33	in-context Arg1:T36 Arg2:T37	
R34	target Arg1:T39 Arg2:T32	
T40	Action 653 660	reveals
T41	Concept 553 566	Superposition
R35	subject Arg1:T40 Arg2:T41	
T42	Concept 665 669	path
R36	target Arg1:T40 Arg2:T42	
T43	Concept 598 611	poliovirus 23
T44	Concept 616 628	norovirus 24
T45	Concept 574 594	elongation complexes
R37	has-part Arg1:T45 Arg2:T43	
R38	has-part Arg1:T45 Arg2:T44	
T46	Concept 638 652	SARS-CoV NSP12
R39	has-part Arg1:T46 Arg2:T44	
R40	has-part Arg1:T46 Arg2:T45	
T47	Concept 677 680	RNA
R41	causes Arg1:T47 Arg2:T42	
T48	Concept 690 701	active site
R42	in-place Arg1:T47 Arg2:T48	
T49	Action 706 715	indicates
R43	subject Arg1:T49 Arg2:T41	
T50	Concept 716 727	amino acids
R44	target Arg1:T49 Arg2:T50	
T51	Action 740 747	binding
R45	subject Arg1:T51 Arg2:T50	
T52	Action 751 760	catalysis
R46	subject Arg1:T52 Arg2:T50	
T53	Concept 781 790	particles
T54	Concept 770 780	virus-like
T55	Concept 761 769	SARS-CoV
R47	has-property Arg1:T53 Arg2:T54	
R48	has-part Arg1:T55 Arg2:T53	
T56	Action 798 807	formation
T57	Action 829 835	depend
R49	subject Arg1:T57 Arg2:T56	
T58	Concept 854 864	E proteins
T59	Concept 874 884	N proteins
R50	in-context Arg1:T57 Arg2:T58	
R51	in-context Arg1:T57 Arg2:T59	
